A computational model for particle size influence on drug absorption during controlled-release colonic delivery

Journal of Controlled Release

Volumn 86, Issue 2-3, 2003, Pages 293-304

  Waterman, Kenneth C ^a   Sutton, Steven C ^a  

^a PFIZER INC   (United States)

Author keywords

Colonic drug absorption; Controlled release drug delivery; Drug solubilization; Particle size

Indexed keywords

ARTICLE; COLON ABSORPTION; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DOSE CALCULATION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG SOLUBILITY; HUMAN; MOLECULAR MODEL; NONHUMAN; PARTICLE SIZE; PREDICTION; PRIORITY JOURNAL;

COLON; DELAYED-ACTION PREPARATIONS; INTESTINAL ABSORPTION; MODELS, BIOLOGICAL; PARTICLE SIZE; SOLUBILITY;

EID: 0037449499     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(02)00418-2     Document Type: Article

References (33)

1. Fincher J.H. Particle size of drugs and its relationship to absorption and activity. J. Pharm. Sci. 57:1968;1825-1835.
2. Kaneniwa N., Wataki N. Dissolution of slightly soluble drugs. IV. Effect of particle size of sulfonamides on in vitro dissolution rate and in vivo absorption rate, and their relation to solubility. Chem. Pharm. Bull. 26:1978;813-826.
3. Kaneniwa N., Watari N., Ijima H. Dissolution of slightly soluble drugs. V. Effect of particle size on gastrointestinal drug absorption and its relation to solubility. Chem. Pharm. Bull. 26:1978;2603-2614.
4. Hintz R.J., Johnson K.C. The effect of particle size distribution on dissolution rate and oral absorption. Int. J. Pharm. 51:1989;9-17.
5. Lu A.T.K., Frisella M.E., Johnson K.C. Dissolution modeling: factors affecting the dissolution rates of polydisperse powders. Pharm. Res. 10:1993;1308-1314.
6. Scholz A., Abrahamsson B., Diebold S.M., Kostewicz E., Polentarutti B.I., Ungell A.-L., Dressman J.B. Influence of hydrodynamics and particle size on the absorption of felodipine in labradors. Pharm. Res. 19:2002;42-96.
7. Ganog W.F. Review of Medical Physiology. 13th Edition: 1987;424 Appleton and Lange, Norwalk, CT.
8. Bouchoucha M., Thomas S.R. Error analysis of classic colonic transit time estimates. Am. J. Gastrointest. Liver Physiol. 279:2000;G520-G527.
9. Hammer J., Phillips S.F. Fluid loading of the human colon: effects on segmental transit and stool composition. Gastroenterology. 105:1993;988-998.
10. Verma R.K., Krishna D.M., Garg S. Formulation aspects in the development of osmotically controlled oral drug delivery systems. J. Control. Release. 79:2002;7-27.
11. Verma R.K., Mishra B., Garg S. Osmotically controlled oral drug delivery. Drug Dev. Ind. Pharm. 26:2000;695-708.
12. Theeuwes F. Elementary osmostic pump. J. Pharm. Sci. 64:1975;1987-1991.
13. Colombo P., Bettini R., Santi P., Peppas N.A. Swellable matrices for controlled drug delivery: gel-layer behaviour, mechanism and optimal performance. PSTT. 3:2000;198-204.
14. Rao K.V.R., Devi K.P. Swelling controlled-release systems: recent developments and applications. Int. J. Pharm. 48:1988;1-13.
15. Pitsiu M., Sathyan G., Gupta S., Verotta D. A sermiparametric deconvolution model to establish in vivo-vitro correlation applied to OROS oxybutynin. J. Pharm. Sci. 90:2001;702-712.
16. R.I. Macey, G.F. Oster (programmed by T. Zahnley), Berkeley Madonna™ 8.0.1, available from www.berkeleymadonna.com, Berkeley, CA, 2001.
17. Systems Thinking Experiential Learning Laboratory (STELLA), software available from High Performance Systems, Inc., Lebannon, NH, 2000.
18. Sutton S.C. The use of pharmacokinetic profiles to drive the formulation development of modified release dosage forms. AAPS Conference on Pharmaceutics and Drug Delivery: 2002;AAPS, Arlington, VA.
19. Bornemann F. Runge-Kutta methods, trees and mathematica. SIAM J. Appl. Math. 2:2001;1-13.
20. Oh D.-M., Curl R.L., Amidon G.L. Estimating the fraction dose absorbed from suspensions of poorly soluble compounds in humans: a mathematical model. Pharm. Res. 10:1993;264-270.
21. Scolapio J.S., Camiller M., von der Ohe M.R., Hanson R.B. Ascending colon response to feeding: evidence for a 5-hydroxytryptamine-3 mechanism. Scand. J. Gastroenterol. 30:1995;562-567.
22. Badley A.D., Camilleri M., O'Connor M.K. Noninvasive measurement of human ascending colon volume. Nucl. Med. Commun. 14:1993;485-489.
23. C. Wilson, personal communication.
24. Sutton S.C., Rinaldi M.T.S., McCarthy J.M., Vukovinsky K.E. A statistical method for the determination of absorption rate constant estimated using the single pass intestinal perfusion model and multiple linear regression. J. Pharm. Sci. 91:2002;1046-1053.
25. Lennernas H. Animal perfusion studies. Drugs Pharm. Sci. 106:2000;73-98.
26. 14C-PEG-3350 methods to determine water absorption in the rat single pass intestinal perfusion model, Pharm. Sci. 3(3) (2001) article 25.
27. Bohets H., Annaert P., Mannens G., Van Beijsterveldt L., Anciaux K., Verboven P., Meuldermans W., Lavrijsen K. Strategies for absorption screening in drug discovery and development. Curr. Top. Med. Chem. 1:2001;367-383.
28. Lennernäs H., Palm K., Fagerholm U., Artursson P. Comparison between active and passive transport in human intestinal epithelial (Caco-2) cells in vitro and human jejunum in vivo. Int. J. Pharm. 127:1996;103-107.
29. Nugent S.G., Kumar D., Rampton D.S., Evans D.F. Intestinal luminal pH in inflammatory bowel disease: possible determinants and implications for therapy with aminosalicylates and other drugs. Gut. 48:2001;571-577.
30. Gruber P., Longer M.A., Robinson J.R. Some biological issues in oral, controlled drug delivery. Adv. Drug Deliv. Rev. 1:1987;1-18.
31. Amidon G.L., Lennernäs H., Shah V.P., Crison J.R. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro and in vivo bioavailability. Pharm. Res. 12:1995;413-420.
32. Lipka E., Amidon G.L. Setting bioequivalence requirements for drug development based on preclinical data: optimizing oral drug delivery systems. J. Control. Release. 62:1999;41-49.
33. Sutton S.C. Use of the dog colon model and a physiologic-pharmacokinetic computer model to simulate controlled release plasma profiles. Proc. Inter. Symp. Control. Release Bioactive Mater. 27:2000;57-58.